Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Oncternal Therapeutics (ONCT) Q4 2023 Earnings
ONCT
7
Mar
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-3.11
-2.12
-1.13
-0.14
Details
Expected EPS
-3.07
Actual EPS
-3.11
Surprise EPS
-0.04
Surprise Percent
+1.3%
Description
Oncternal Therapeutics (ONCT) has reported earnings of -3.11 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist